Home › NDC Lookup › RxCUI directory › RxCUI 2393795

Calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sod... — RxCUI 2393795

RxNorm drug concept · Semantic clinical drug
RxCUI 2393795 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2393795
Official nameCalcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascalcium/magnesium/potassium/sodium oxybates 0.5 GM per 1 ML Oral Solution; calcium / magnesium / potassium / sodium oxybates 0.5 GM in 1 mL Oral Solution; calcium oxybate 0.234 GM / magnesium oxybate 0.096 GM / potassium oxybate 0.13 GM / sodium oxybate 0.04 GM per 1 ML Oral Solution; calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / K+ oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution; calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / Pot oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)9,091 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Calcium, Magnesium, Potassium, and Sodium Oxybate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • For narcolepsy, Xywav is designed to be taken in two separate doses because it leaves your body very quickly — the half-life is less than an hour. If you took it all at once, it wo...
  • Why do I have to take this medicine in the middle of the night? Can't I just take it all at once before bed?
  • Yes, this matters a lot. Eating — especially a high-fat meal — can reduce the amount of Xywav your body absorbs by a meaningful amount. That could make it less effective or cause u...
  • Is it really that important not to eat before taking it?
📖 Read our full Calcium, Magnesium, Potassium, and Sodium Oxybate guide →

🕸️ Concept Web — How Calcium oxybate 234 MG/ML / magnesium oxybate 96... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Calcium oxybate 234 MG/ML / magnesium oxybate 96 MG/ML / potassium oxybate 130 MG/ML / sodium oxybate 40 MG/ML Oral Solution RxCUI 2393795

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Oxybate 2387302
    • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate 2393796
    • Calcium oxybate 2387307
    • Magnesium oxybate 2387308
    • Potassium oxybate 2387309
    • Sodium oxybate 9899
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xywav 2393800
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxybate Oral Solution 378683
    • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Solution 2647686
    • Oxybate Oral Liquid Product 2392730
    • Oxybate Oral Product 2392731
    • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Liquid Product 2662428
    • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Product 2660340
    • Oxybate Oral Solution [Xywav] 2393801
    • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Solution [Xywav] 2655868
    • +5 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Calcium oxybate 234 MG/ML SCDC · 2393609
  • Magnesium oxybate 96 MG/ML SCDC · 2393610
  • Potassium oxybate 130 MG/ML SCDC · 2393611
  • Sodium oxybate 40 MG/ML SCDC · 2393612
  • Oxybate Oral Solution SCDF · 378683
  • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Solution SCDFP · 2647686
  • Oxybate Oral Liquid Product SCDG · 2392730
  • Oxybate Oral Product SCDG · 2392731
  • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Liquid Product SCDGP · 2662428
  • Calcium oxybate / magnesium oxybate / potassium oxybate / sodium oxybate Oral Product SCDGP · 2660340

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2393795 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68727-0150-01 180 mL in 1 BOTTLE, PLASTIC (68727-150-01) XYWAV Jazz Pharmaceuticals, Inc. 2020-11-02
Observed labelers: Jazz Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.